Pacira BioSciences
PCRX
PCRX
182 hedge funds and large institutions have $1.3B invested in Pacira BioSciences in 2016 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 60 increasing their positions, 59 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
2% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 59
4% less capital invested
Capital invested by funds: $1.35B → $1.3B (-$47.4M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
182
Holding in Top 10
4
Calls
$23.8M
Puts
$22.6M
Top Buyers
| 1 | +$37.5M | |
| 2 | +$28.8M | |
| 3 | +$26.8M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$20.4M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$18.1M |
Top Sellers
| 1 | -$82.2M | |
| 2 | -$39.8M | |
| 3 | -$26.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25.8M |
| 5 |
Goldman Sachs
New York
|
-$16.3M |